Ronny Drapkin
Impact in
- Reproductive Medicine top 0.02%
- Ovarian cancer diagnosis and treatment
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
-
- Ovarian cancer diagnosis and treatment 87
-
- Cancer Genomics and Diagnostics 23
- Cancer-related molecular mechanisms research 21
- Co-authors
- Christopher P. Crum (13 shared papers)Alison M. Karst (15 shared papers)Danny Reinberg (13 shared papers)Keren Levanon (7 shared papers)Michelle Hirsch (24 shared papers)Alexander Miron (7 shared papers)David M. Livingston (9 shared papers)David W. Kindelberger (4 shared papers)
- Journals
- Nature Communications (21 papers)Gynecologic Oncology (17 papers)Nature (14 papers)Clinical Cancer Research (12 papers)Cancer Research (10 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ronny Drapkin
236 papers receiving 31.2k citations
Ronny Drapkin's Hit Papers
Peers
Comparison fields: 5 of 170
- Reproductive Medicine 6.3k
- Cancer Research 8.2k
- Oncology 7.5k
- Molecular Biology 16.3k
- Obstetrics and Gynecology 1.6k
Countries citing papers authored by Ronny Drapkin
This map shows the geographic impact of Ronny Drapkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronny Drapkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronny Drapkin more than expected).
Fields of papers citing papers by Ronny Drapkin
This network shows the impact of papers produced by Ronny Drapkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronny Drapkin. The network helps show where Ronny Drapkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronny Drapkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 2 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 3 | Whole–genome characterization of chemoresistant ovarian cancer Hit paper breakdown → | 2015 | 1233 |
| 4 | Rethinking ovarian cancer: recommendations for improving outcomes Hit paper breakdown → | 2011 | 1042 |
| 5 | Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Hit paper breakdown → | 2015 | 915 |
| 6 | 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers Hit paper breakdown → | 2010 | 804 |
| 7 | A candidate precursor to serous carcinoma that originates in the distal fallopian tube Hit paper breakdown → | 2006 | 735 |
| 8 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 9 | 2003 | 602 | |
| 10 | High grade serous ovarian carcinomas originate in the fallopian tube Hit paper breakdown → | 2017 | 568 |
| 11 | 2001 | 563 | |
| 12 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 13 | Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy Hit paper breakdown → | 2011 | 501 |
| 14 | 2005 | 483 | |
| 15 | 2012 | 481 | |
| 16 | Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models Hit paper breakdown → | 2013 | 476 |
| 17 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 18 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 19 | 1994 | 412 | |
| 20 | 2007 | 393 |
About Ronny Drapkin
Ronny Drapkin is a scholar working on Reproductive Medicine, Cancer Research, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 239 papers that have together received 31.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (87 papers), RNA modifications and cancer (24 papers), Cancer Genomics and Diagnostics (23 papers), Cancer-related molecular mechanisms research (21 papers), Genetic factors in colorectal cancer (18 papers), BRCA gene mutations in cancer (17 papers), DNA Repair Mechanisms (16 papers) and Reproductive Biology and Fertility (16 papers). The work is most often cited by research in Reproductive Medicine (6.3k citations), Cancer Research (8.2k citations), Oncology (7.5k citations), Molecular Biology (16.3k citations) and Obstetrics and Gynecology (1.6k citations). Ronny Drapkin has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Christopher P. Crum, Alison M. Karst, Danny Reinberg, Keren Levanon, Michelle Hirsch, Alexander Miron, David M. Livingston, David W. Kindelberger, Ruth Perets and Paul Kroeger. Their work appears in journals such as Nature Communications, Gynecologic Oncology, Nature, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.